These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 29027620

  • 21. Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol.
    McGowan CE, Saha S, Chu G, Resnick MB, Moss SF.
    South Med J; 2009 May; 102(5):493-7. PubMed ID: 19373153
    [Abstract] [Full Text] [Related]

  • 22. Sodium polystyrene sulfonate use revisited.
    Varriale P, Ngai L.
    Am J Med; 2014 Aug; 127(8):e37. PubMed ID: 24269324
    [No Abstract] [Full Text] [Related]

  • 23. Sodium polystyrene sulfonate versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in the emergency department.
    Hasara S, Dubey J, Amatea J, Finnigan N.
    Am J Emerg Med; 2023 Mar; 65():59-64. PubMed ID: 36586223
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Evaluation of Appropriate Sodium Polystyrene Sulfonate Use With a Hyperkalemia Order Set: A Pilot Study.
    Mueller ZT, Crannage AJ.
    J Pharm Pract; 2019 Oct; 32(5):493-498. PubMed ID: 29642732
    [Abstract] [Full Text] [Related]

  • 26. Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia.
    Batterink J, Lin J, Au-Yeung SH, Cessford T.
    Can J Hosp Pharm; 2015 Oct; 68(4):296-303. PubMed ID: 26327703
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [The presence of crystals of sodium polystyrene sulfonate in the colonic wall: innocent bystander or pathogenic factor?].
    Capitanini A, Bozzoli L, Rollo S, Pirolo B, Giannese D, Zullo C, Cupisti A.
    G Ital Nefrol; 2016 Oct; 33(2):. PubMed ID: 27067217
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of effectiveness and safety of sodium polystyrene sulfonate and sodium zirconium cyclosilicate for treatment of hyperkalemia in hospitalized patients.
    Sullivan E, Ruegger M, Dunne I, Sutaria N, Towers WF.
    Am J Health Syst Pharm; 2023 Sep 07; 80(18):1238-1246. PubMed ID: 37335862
    [Abstract] [Full Text] [Related]

  • 35. Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors.
    Ren H, Leon SJ, Whitlock R, Rigatto C, Komenda P, Bohm C, Collister D, Tangri N.
    Clin Kidney J; 2022 Sep 07; 15(9):1713-1719. PubMed ID: 36003673
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.
    Davidson JP, King AJ, Kumaraswamy P, Caldwell JS, Korner P, Blanks RC, Jacobs JW.
    J Cardiovasc Pharmacol Ther; 2018 May 07; 23(3):244-253. PubMed ID: 29130735
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of hyperkalemia in patients with chronic kidney disease: a comparison of calcium polystyrene sulphonate and sodium polystyrene sulphonate.
    Nasir K, Ahmad A.
    J Ayub Med Coll Abbottabad; 2014 May 07; 26(4):455-8. PubMed ID: 25672163
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.